glp 1 agonist in heart failure GLP-1 receptor agonists and myocardial metabolism atrial fibrillation Effects of GLP-1 Receptor Agonists

doi: 10.1093/ajhp/zxz284

4.1 The ApelinAPJ axis Apelin was identified as the endogenous ligand for the APJ receptor, a G proteincoupled receptor structurally related to the angiotensin II type 1 receptor but functionally distinct from the reninangiotensin system (Tatemoto et al., 1998)

Due to massive and persistent cultural and patient resistance and restrictive regulations, opioid-based OUD treatments like methadone and buprenorphine are used by a small fraction of people who could benefit from them

This work was supported in part by Arnold Ventures

GLP-1 Receptor Agonist Market Segmentation Analysis By Product By product, the semaglutide segment accounted for a share of 51.23% in 2025, owing to its broad regulatory approvals across type 2 diabetes and obesity and proven cardiovascular risk reduction benefits